Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity
- PMID: 22948112
- PMCID: PMC3660061
- DOI: 10.18632/oncotarget.626
Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity
Abstract
The neuropilins (Nrps) are multifunctional proteins involved in development, immunity and cancer. Neuropilin-1 (Nrp1), or its homologue neuropilin-2 (Nrp2), are coreceptors that enhance responses to several growth factors (GFs) and other mediators. Nrps are coreceptors for the class 3 semaphorins (SEMA3), involved in axonal guidance, and several members of the vascular endothelial growth factor (VEGF) family. However, recent findings reveal they have a much broader spectrum of activity. They bind transforming growth factor β1 (TGF-β1) and its receptors, hepatocyte growth factor (HGF) and its receptor (cMet), platelet derived growth factor (PDGF) and its receptors, fibroblast growth factors (FGFs), and integrins. Nrps also promote Hedgehog signaling. These ligands and pathways are all relevant to angiogenesis and wound healing. In the immune system, the Nrps are expressed primarily by dendritic cells (DCs) and regulatory T cells (Tregs), and exert mainly inhibitory effects. In cancer, Nrps have been linked to a poor prognosis, which is consistent with their numerous interactions with ligands and receptors that promote tumor progression. We hypothesize that Nrps boost responses by capturing ligands, regulating GF receptor expression, endocytosis and recycling, and possibly also by signaling independently. Importantly, they promote epithelial-mesenchymal transition (EMT), and the survival of cancer stem cells. The recent finding that Nrps bind and internalize cell-penetrating peptides (CPPs) with arginine/lysine-rich C-terminal motifs (C-end rule; e.g., RXXR) is of interest. These CPPs can be coupled to large drugs for cancer therapy. Almost all studies have been preclinical, but findings suggest Nrps are excellent targets for anti-cancer drug development.
Figures

Comment in
-
Neurophilin-1 in tumor growth.Oncotarget. 2012 Nov;3(11):1259. doi: 10.18632/oncotarget.734. Oncotarget. 2012. PMID: 23175449 Free PMC article. No abstract available.
Similar articles
-
Neuropilins and liver.World J Gastroenterol. 2015 Jun 21;21(23):7065-73. doi: 10.3748/wjg.v21.i23.7065. World J Gastroenterol. 2015. PMID: 26109793 Free PMC article. Review.
-
Neuropilins: novel targets for anti-angiogenesis therapies.Cell Adh Migr. 2007 Apr-Jun;1(2):56-61. doi: 10.4161/cam.1.2.4490. Epub 2007 Apr 25. Cell Adh Migr. 2007. PMID: 19329879 Free PMC article. Review.
-
Multifaceted role of neuropilins in cancer.Curr Med Chem. 2011;18(23):3563-75. doi: 10.2174/092986711796642544. Curr Med Chem. 2011. PMID: 21756227 Review.
-
Jack of many trades: Multifaceted role of neuropilins in pancreatic cancer.Cancer Med. 2018 Oct;7(10):5036-5046. doi: 10.1002/cam4.1715. Epub 2018 Sep 14. Cancer Med. 2018. PMID: 30216699 Free PMC article. Review.
-
Neuropilins: role in signalling, angiogenesis and disease.Chem Immunol Allergy. 2014;99:37-70. doi: 10.1159/000354169. Epub 2013 Oct 17. Chem Immunol Allergy. 2014. PMID: 24217602 Review.
Cited by
-
Characterization of Class-3 Semaphorin Receptors, Neuropilins and Plexins, as Therapeutic Targets in a Pan-Cancer Study.Cancers (Basel). 2020 Jul 6;12(7):1816. doi: 10.3390/cancers12071816. Cancers (Basel). 2020. PMID: 32640719 Free PMC article.
-
Anti-neuropilin-1 monoclonal antibody suppresses the migration and invasion of human gastric cancer cells via Akt dephosphorylation.Exp Ther Med. 2018 Aug;16(2):537-546. doi: 10.3892/etm.2018.6234. Epub 2018 May 30. Exp Ther Med. 2018. PMID: 30116312 Free PMC article.
-
Molecular ZIP codes in targeted drug delivery.Proc Natl Acad Sci U S A. 2022 Jul 12;119(28):e2200183119. doi: 10.1073/pnas.2200183119. Epub 2022 Jun 30. Proc Natl Acad Sci U S A. 2022. PMID: 35771944 Free PMC article. Review.
-
Stimulation of medulloblastoma stem cells differentiation by a peptidomimetic targeting neuropilin-1.Oncotarget. 2018 Feb 16;9(20):15312-15325. doi: 10.18632/oncotarget.24521. eCollection 2018 Mar 16. Oncotarget. 2018. PMID: 29632646 Free PMC article.
-
NRP1 promotes cell migration and invasion and serves as a therapeutic target in nasopharyngeal carcinoma.Int J Clin Exp Pathol. 2018 May 1;11(5):2460-2469. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31938358 Free PMC article.
References
-
- Pellet-Many C, Frankel P, Jia H, Zachary I. Neuropilins: structure, function and role in disease. Biochem J. 2008;411:211–226. - PubMed
-
- Uniewicz KA, Fernig DG. Neuropilins: a versatile partner of extracellular molecules that regulate development and disease. Front Biosci. 2008;13:4339–4360. - PubMed
-
- Romeo PH, Lemarchandel V, Tordjman R. Neuropilin-1 in the immune system. Adv Exp Med Biol. 2002;515:49–54. - PubMed
-
- Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K, von Boehmer H, Buer J, Hansen W. Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol. 2004;34:623–630. - PubMed
-
- Bielenberg DR, Pettaway CA, Takashima S, Klagsbrun M. Neuropilins in neoplasms: expression, regulation, and function. Exp Cell Res. 2006;312:584–593. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous